R. Mata

发表

Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-α 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients

M. González-Escribano, J. Pineda, A. Rivero, 2012, PloS one.

Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin.

J. Torre-Cisneros, J. Macías, J. Pineda, 2010, The Journal of antimicrobial chemotherapy.

Virological and immunological stability in HIV infected patients undergoing partial-treatment interruption.

P. Viciana, L. López-Cortés, Fernando Flor-Parra, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Increased regulatory T cell counts in HIV-infected nonresponders to hepatitis B virus vaccine.

M. Leal, Y. Pacheco, P. Viciana, 2010, The Journal of infectious diseases.

Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial

S. Arias-Santiago, E. Ruiz-Mateos, P. Viciana, 2020, Stem cells translational medicine.

Liver toxicity of antiretroviral combinations including fosamprenavir plus ritonavir 1400/100 mg once daily in HIV/hepatitis C virus-coinfected patients.

J. Macías, J. Pineda, A. Rivero, 2011, AIDS patient care and STDs.

High Seroprevalence But Low Incidence of HCV Infection in a Cohort of Patients With Sexually Transmitted HIV in Andalusia, Spain

A. Rivero, L. López-Cortés, Jesús Santos, 2009, Journal of the International Association of Physicians in AIDS Care.

Clinical and Pharmacokinetic Data Support Once-Daily Low-Dose Boosted Saquinavir (1,200 Milligrams Saquinavir with 100 Milligrams Ritonavir) in Treatment-Naive or Limited Protease Inhibitor-Experienced Human Immunodeficiency Virus-Infected Patients

P. Viciana, L. López-Cortés, A. Marín-Niebla, 2007, Antimicrobial Agents and Chemotherapy.

Very Low Prevalence and No Clinical Significance of Occult Hepatitis B in a Cohort of HIV-Infected Patients with Isolated Anti-HBc Seropositivity: The BHOI Study

A. Del Arco, J. De La Torre, L. López-Cortés, 2008, HIV clinical trials.

Once-daily saquinavir-sgc plus low-dose ritonavir (1200/100 mg) in combination with efavirenz: pharmacokinetics and efficacy in HIV-infected patients with prior antiretroviral therapy.

J. Pachón, P. Viciana, L. López-Cortés, 2003, Journal of acquired immune deficiency syndromes.

Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy

J. Macías, J. Pineda, Á. Camacho, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Nevirapine-based antiretroviral therapy is associated with lower plasma hepatitis C virus viral load among HIV/hepatitis C virus-coinfected patients.

J. Pineda, A. Rivero, L. López-Cortés, 2010 .

Discontinuation of antiretroviral therapy in patients with chronic HIV infection: clinical, virologic, and immunologic consequences.

J. Cisneros, A. de Alarcón, P. Viciana, 2005, AIDS patient care and STDs.

J. Macías, J. Pineda, Á. Camacho, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010

M. Leal, F. Fernández-Cuenca, P. Viciana, 2011, Virology Journal.